India’s ATLAS expands to OTCs
This article was originally published in The Tan Sheet
Executive Summary
ATLAS Laboratories and Pharmaceuticals, an Indian manufacturer of Rx hormonal preparations and anti-hypertensive products, plans to enter the over-the-counter segment with a line of women's health products, the company announces Oct. 16. ATLAS Executive Director Ashwin Kapur says the New Delhi-based firm "will leverage our vertical presence in the ethical segment, to develop a strong network for OTC products" for women, whom he calls "the backbone of our society." Kapur adds the Indian OTC channel's average compound annual growth rate of 14 percent attracted the firm to the market. The company says it intends to add a large R&D facility and look for international partnerships to launch new molecules in the Indian market